Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Fulcrum Therapeutics Inc (FULC)

Fulcrum Therapeutics Inc (FULC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Kaplan Fox Alerts Investors of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) to Possible Securities Law Violations NewMediaWire - Tue Aug 11, 3:00PM CDT

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

FULC : 3.72 (+0.81%)
Kaplan Fox Notifies Investors of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) of an Investigation Into Potential Securities Law Violations NewMediaWire - Thu Aug 6, 2:30PM CDT

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

FULC : 3.72 (+0.81%)
Kaplan Fox Encourages Investors of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) to Contact the Firm Regarding Potential Securities Law Violations NewMediaWire - Tue Aug 4, 1:30PM CDT

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

FULC : 3.72 (+0.81%)
Kaplan Fox Reminds Investors of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) of an Ongoing Investigation Into Potential Securities Law Violations NewMediaWire - Thu Jul 30, 1:00PM CDT

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

FULC : 3.72 (+0.81%)
Kaplan Fox is Investigating Fulcrum Therapeutics, Inc. (NASDAQ: FULC) for Potential Securities Law Violations - Investors Encouraged to Contact the Firm NewMediaWire - Tue Jul 28, 12:30PM CDT

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

FULC : 3.72 (+0.81%)
Kaplan Fox is Investigating Fulcrum Therapeutics, Inc. (NASDAQ: FULC) for Potential Securities Law Violations - Investors are Encouraged to Contact the Firm NewMediaWire - Thu Jul 23, 7:15AM CDT

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

FULC : 3.72 (+0.81%)
Kaplan Fox Announces an Investigation Into Fulcrum Therapeutics, Inc. (NASDAQ: FULC) for Potential Securities Law Violations NewMediaWire - Tue Jul 21, 2:00PM CDT

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

FULC : 3.72 (+0.81%)
Kaplan Fox Encourages Investors of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) to Contact the Firm to Learn About Their Legal Rights NewMediaWire - Thu Jul 16, 8:30AM CDT

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

FULC : 3.72 (+0.81%)
Kaplan Fox & Kilsheimer LLP Alerts Fulcrum Therapeutics, Inc. (NASDAQ: FULC) Investors to a Securities Investigation NewMediaWire - Wed Jul 15, 9:45AM CDT

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

FULC : 3.72 (+0.81%)
FULC Investor Alert: Levi & Korsinsky Investigates Fulcrum Therapeutics, Inc. (FULC) for Potential Securities Fraud Business Wire - Thu Jun 4, 1:53PM CDT

Fulcrum Therapeutics, Inc. lost approximately half its market value after disclosing FDA safety concerns leading the company to discontinue its lead sickle-cell candidate.*

FULC : 3.72 (+0.81%)

Barchart Exclusives

Target Appoints Its First-Ever AI Exec as the Retailer Pushes Deeper Into Artificial Intelligence. What It Means for TGT Stock. Barchart - Wed Aug 12, 6:30PM CDT
Target appointed Chandhu Nair as its first chief artificial intelligence officer, effective Aug. 24, as the retailer expands its use of AI across inventory, operations, and customer experience. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.